Esperion Therapeutics: 2Q Earnings Snapshot
ANN ARBOR, Mich. (AP) _ Esperion Therapeutics Inc. (ESPR) on Thursday reported a loss of $45.7 million in its second quarter.
The Ann Arbor, Michigan-based company said it had a loss of $1.71 per share.
The results surpassed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of $1.77 per share.
Esperion Therapeutics shares have decreased 32 percent since the beginning of the year. The stock has decreased slightly in the last 12 months.